All the news Showing 10 of 43 articles from: EgyptGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Screening and testing policy Egypt’s Hepatitis C initiative examines over 1.5 million citizens in 6 days Egypt Today / 28 September 2020 Hepatocellular carcinoma (HCC) Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... Screening and testing policy Over 1.6 million students screened for Hepatitis C since October: Minister Egypt Independent / 06 January 2020 Transfusion and medical procedures The impact of Egypt's mass hepatitis C screening on health care workers Devex / 11 December 2019 Promoting hepatitis testing Over 60 million tested for hepatitis C in Egypt Egypt Today / 17 October 2019 Screening policy 30 million screened for hepatitis C in four months in Egypt Keith Alcorn / 11 April 2019 Egypt screened almost 30 million people for hepatitis C in the first four months of a national screening programme that kicked off in October 2018, Egyptian researchers announced at The International Liver Congress ... Screening policy Same-day hepatitis C treatment initiation can be achieved at large scale, Egyptian pilot study shows Keith Alcorn / 11 April 2019 Screening for hepatitis C, confirmation of chronic infection by point-of-care viral load testing and treatment initiation can all be achieved on the same day in a community setting, Egyptian researchers reported at The ... Screening policy Egypt's government gives more info about anti-hepatitis C screenings for refugees Ahram Online / 20 March 2019 Hepatitis C elimination In Egypt, Viral Hepatitis Elimination Starts With a Village: An Interview With Dr. Ammal Metwally IS Global / 05 February 2019 Treatment outcomes Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost Michael Carter / 01 February 2019 Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved ... ← First12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive